GSE158632 3 V 4 OXYQUINOLINE HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE158632 3 V 4 OXYQUINOLINE HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE158632 3 V 4 OXYQUINOLINE HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE158632 3 V 4 OXYQUINOLINE HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE158632 3 V 4 OXYQUINOLINE HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

colony stimulating factor 2 receptor subunit alpha

Gene

uncharaterized LOC112694756

Gene

mitochondrial elongation factor 1 upstream open reading frame

Gene

thymosin beta 15C

Gene

corin, serine peptidase

Gene

glutamate rich 4

Gene

Ras association domain family member 8

Gene

transmembrane protein 98

Gene

CaM kinase like vesicle associated

Gene

Sp9 transcription factor

  • Gene

    colony stimulating factor 2 receptor subunit alpha


  • Gene

    uncharaterized LOC112694756


  • Gene

    mitochondrial elongation factor 1 upstream open reading frame


  • Gene

    thymosin beta 15C


  • Gene

    corin, serine peptidase


  • Gene

    glutamate rich 4


  • Gene

    Ras association domain family member 8


  • Gene

    transmembrane protein 98


  • Gene

    CaM kinase like vesicle associated


  • Gene

    Sp9 transcription factor

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.